The association between the gene encoding 5-lipoxygenase activating protein and abdominal aortic aneurysms

被引:10
作者
Bisoendial, Radjesh J. [1 ]
Tanck, Michael W. [2 ]
Golledge, Jonathan [3 ]
Broekhuizen, Lysette N. [4 ]
Legemate, Dink A. [5 ]
Stroes, Erik S. G. [4 ]
Norman, Paul E. [6 ]
机构
[1] Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1100 DD Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Acad Med Ctr, Amsterdam, Netherlands
[3] James Cook Univ, Sch Med, Vasc Biol Unit, Townsville, Qld, Australia
[4] Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands
[5] Acad Med Ctr, Dept Vasc Surg, NL-1100 DD Amsterdam, Netherlands
[6] Univ Western Australia, Sch Surg, Fremantle, WA, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Aneurysm formation; Inflammation; Leukotrienes; 5-Lipoxygenase activating protein; MYOCARDIAL-INFARCTION; POPULATION; RISK; VARIANTS; PATHOGENESIS; DISEASE; STROKE; TRIAL;
D O I
10.1016/j.atherosclerosis.2011.10.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Genetic variation in the gene ALOX5AP, encoding arachidonate 5-lipoxygenase-activating protein, have been suggested to increase risk for myocardial infarction and stroke. Leukotrienes (LTs) that derive from the 5-lipoxygenase (5-LO) cascade have been implicated in the pathogenesis of abdominal aortic aneurysm (AAA). Methods and results: The association of the ALOX5AP haplotypes with AAA was assessed in a large population-based cohort of 613 men aged >= 65 years with screen-detected AAAs and 707 randomly selected age-matched controls without AAA. Taqman assays were used to assess seven previously described single nucleotide polymorphisms (SNPs) of ALOX5AP. Haplotypes A and B were defined by the four SNPs (SG13S25, SG13S114, SG13S89, SG13S32) and (SG13S377, SG13S114, SG13S41, SG13S35), respectively. After adjustment for cardiovascular risk factors, there were no significant differences in the distribution of ALOX5AP haplotypes between cases and controls. Conclusion: A genetic predisposition to up-regulation of LT mediators is unlikely to play a dominant role in the pathogenesis of AAA. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 15 条
[1]   Inhibited aortic aneurysm formation in BLT1-deficient mice [J].
Ahluwalia, Neil ;
Lin, Alexander Y. ;
Tager, Andrew M. ;
Pruitt, Ivy E. ;
Anderson, Thomas J. T. ;
Kristo, Fjoralba ;
Shen, Dongxiao ;
Cruz, Anna R. ;
Aikawa, Masanori ;
Luster, Andrew D. ;
Gerszten, Robert E. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (01) :691-697
[2]   ALOX5AP gene variants and risk of coronary artery disease:: an angiography-based study [J].
Girelli, Domenico ;
Martinelli, Nicola ;
Trabetti, Elisabetta ;
Olivieri, Oliviero ;
Cavallari, Ugo ;
Malerba, Giovanni ;
Busti, Fabiana ;
Friso, Simonetta ;
Pizzolo, Francesca ;
Pignatti, Pier Franco ;
Corrocher, Roberto .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (09) :959-966
[3]   Abdominal aortic aneurysm - Pathogenesis and implications for management [J].
Golledge, Jonathan ;
Muller, Juanita ;
Daugherty, Alan ;
Norman, Paul .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (12) :2605-2613
[4]   Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease [J].
Haeggstrom, Jesper Z. ;
Funk, Colin D. .
CHEMICAL REVIEWS, 2011, 111 (10) :5866-5898
[5]   Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction - A randomized trial [J].
Hakonarson, H ;
Thorvaldsson, S ;
Helgadottir, A ;
Gudbjartsson, D ;
Zink, F ;
Andresdottir, M ;
Manolescu, A ;
Arnar, DO ;
Andersen, K ;
Sigurdsson, A ;
Thorgeirsson, G ;
Jonsson, A ;
Agnarsson, U ;
Bjornsdottir, H ;
Gottskalksson, G ;
Einarsson, A ;
Gudmundsdottir, H ;
Adalsteinsdottir, AE ;
Gudmundsson, K ;
Kristjansson, K ;
Hardarson, T ;
Kristinsson, A ;
Topol, EJ ;
Gulcher, J ;
Kong, A ;
Thorgeirsson, G ;
Stefansson, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (18) :2245-2256
[6]   Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population [J].
Helgadottir, A ;
Gretarsdottir, S ;
St Clair, D ;
Manolescu, A ;
Cheung, J ;
Thorleifsson, G ;
Pasdar, A ;
Grant, SFA ;
Whalley, LJ ;
Hakonarson, H ;
Thorsteinsdottir, U ;
Kong, A ;
Gulcher, J ;
Stefansson, K ;
MacLeod, MJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (03) :505-509
[7]   The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke [J].
Helgadottir, A ;
Manolescu, A ;
Thorleifsson, G ;
Gretarsdottir, S ;
Jonsdottir, H ;
Thorsteinsdottir, U ;
Samani, NJ ;
Gudmundsson, G ;
Grant, SFA ;
Thorgeirsson, G ;
Sveinbjornsdottir, S ;
Valdimarsson, EM ;
Matthiasson, SE ;
Johannsson, H ;
Gudmundsdottir, O ;
Gurney, ME ;
Sainz, J ;
Thorhallsdottir, M ;
Andresdottir, M ;
Frigge, ML ;
Topol, EJ ;
Kong, A ;
Gudnason, V ;
Hakonarson, H ;
Gulcher, JR ;
Stefansson, K .
NATURE GENETICS, 2004, 36 (03) :233-239
[8]   No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population [J].
Koch, Werner ;
Hoppmann, Petra ;
Mueller, Jakob C. ;
Schoemig, Albert ;
Kastrati, Adnan .
GENETICS IN MEDICINE, 2007, 9 (02) :123-129
[9]   Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infariction [J].
Maznyczka, Annette ;
Mangino, Massimo ;
Whittaker, Andrew ;
Braund, Peter ;
Palmer, Tom ;
Tobin, Martin ;
Goodall, Alison H. ;
Bradding, Peter ;
Samani, Nilesh J. .
CLINICAL SCIENCE, 2007, 112 (7-8) :411-416
[10]   Cohort Profile: The Health In Men Study (HIMS) [J].
Norman, Paul E. ;
Flicker, Leon ;
Almeida, Osvaldo P. ;
Hankey, Graeme J. ;
Hyde, Zoe ;
Jamrozik, Konrad .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2009, 38 (01) :48-52